The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation.

Giosafat Spitaleri,Marta Farrero Torres,M. Sabatino,Luciano Potena

The pharmaceutical management of cardiac allograft vasculopathy after heart transplantation.

2020

Giosafat Spitaleri
Marta Farrero Torres
M. Sabatino
Luciano Potena

Cardiac allograft vasculopathy (CAV) is a major limitation to long-term survival after heart transplantation. Its peculiar pathophysiology involves multifactorial pathways including immune-mediated...

Keywords:

Cardiac allograft vasculopathy
Heart transplantation
Pharmacology
Internal medicine
Diabetes mellitus
Immunosuppression
Pathophysiology
Medicine
Cardiology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

101

References

Citations